- SonarMD presented promising results from two studies at Digestive Disease Week (DDW) 2024, demonstrating that their digital platform significantly reduces emergency department visits and inpatient admissions for patients with inflammatory bowel disease (IBD).
- The first study showed an 18% reduction in IBD-related emergency department visits in the first year and a 46% reduction in the second year for the SonarMD cohort compared to the control group. Inpatient admissions decreased by 20% in the first year and 78% in the second year. The second study, over 12 months, also reported lower healthcare utilization, with a 15% reduction in emergency visits and a 14% reduction in inpatient admissions for IBD patients using the platform.
SonarMD touts positive data from digital platform at DDW (Clinical Trials Arena)
0